Search research articles
Contact Us
Filters
Showing results (51-60 of 103) with videos related to
Page
of 11
Sort By:
Journal of Gastrointestinal Oncology
|
November 30, 2017
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer
Sachin G Pai, Benedito A Carneiro, Young Kwang Chae, et al.
The Prostate
|
July 29, 2014
Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancer
Pawel Osmulski, Devalingam Mahalingam, Maria E Gaczynska, et al.
Oncotarget
|
May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancer
Rubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.
Cancer Treatment Reviews
|
January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development
Ricardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Molecular & Cellular Proteomics : MCP
|
January 4, 2012
Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAIL
Eva Szegezdi, Almer M van der Sloot, Devalingam Mahalingam, et al.
Cancers
|
June 27, 2019
Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization
Mark Antkowiak, Ahmed Gabr, Arighno Das, et al.
Cancers
|
May 26, 2018
A Phase II Study of Pelareorep (REOLYSIN<sup>®</sup>) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam, Sanjay Goel, Santiago Aparo, et al.
Annals of Surgical Oncology
|
August 3, 2020
Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement
Brian C Brajcich, David J Bentrem, Anthony D Yang, et al.
British Journal of Cancer
|
July 13, 2023
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)
Devalingam Mahalingam, Siqi Chen, Ping Xie, et al.
British Journal of Clinical Pharmacology
|
March 25, 2020
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Devalingam Mahalingam, Manish R Patel, Jasgit C Sachdev, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 103) with videos related to
Sort By:
Page
of 11
Journal of Gastrointestinal Oncology
|
November 30, 2017
Correlation of tumor mutational burden and treatment outcomes in patients with colorectal cancer
Sachin G Pai, Benedito A Carneiro, Young Kwang Chae, et al.
The Prostate
|
July 29, 2014
Nanomechanical biomarkers of single circulating tumor cells for detection of castration resistant prostate cancer
Pawel Osmulski, Devalingam Mahalingam, Maria E Gaczynska, et al.
Oncotarget
|
May 19, 2018
Systematic review and meta-analysis of selected toxicities of approved <i>ALK</i> inhibitors in metastatic non-small cell lung cancer
Rubens Barros Costa, Ricardo L B Costa, Sarah M Talamantes, et al.
Cancer Treatment Reviews
|
January 21, 2017
Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development
Ricardo Costa, Ami N Shah, Cesar A Santa-Maria, et al.
Molecular & Cellular Proteomics : MCP
|
January 4, 2012
Kinetics in signal transduction pathways involving promiscuous oligomerizing receptors can be determined by receptor specificity: apoptosis induction by TRAIL
Eva Szegezdi, Almer M van der Sloot, Devalingam Mahalingam, et al.
Cancers
|
June 27, 2019
Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization
Mark Antkowiak, Ahmed Gabr, Arighno Das, et al.
Cancers
|
May 26, 2018
A Phase II Study of Pelareorep (REOLYSIN<sup>®</sup>) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma
Devalingam Mahalingam, Sanjay Goel, Santiago Aparo, et al.
Annals of Surgical Oncology
|
August 3, 2020
Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement
Brian C Brajcich, David J Bentrem, Anthony D Yang, et al.
British Journal of Cancer
|
July 13, 2023
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC)
Devalingam Mahalingam, Siqi Chen, Ping Xie, et al.
British Journal of Clinical Pharmacology
|
March 25, 2020
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours
Devalingam Mahalingam, Manish R Patel, Jasgit C Sachdev, et al.
Page
of 11